0001564590-21-056701.txt : 20211112 0001564590-21-056701.hdr.sgml : 20211112 20211112160239 ACCESSION NUMBER: 0001564590-21-056701 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 91 CONFORMED PERIOD OF REPORT: 20210930 FILED AS OF DATE: 20211112 DATE AS OF CHANGE: 20211112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: American Well Corp CENTRAL INDEX KEY: 0001393584 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-39515 FILM NUMBER: 211403274 BUSINESS ADDRESS: STREET 1: 75 STATE STREET STREET 2: 26TH FLOOR CITY: Boston STATE: MA ZIP: 02109 BUSINESS PHONE: 617-205-3500 MAIL ADDRESS: STREET 1: 75 STATE STREET STREET 2: 26TH FLOOR CITY: Boston STATE: MA ZIP: 02109 10-Q 1 amwl-10q_20210930.htm 10-Q amwl-10q_20210930.htm
false Q3 0001393584 --12-31 true true true true true true true 0.113 P5Y P5Y P7Y P5Y P10Y P10Y P8Y7M6D P7Y3M18D P6Y3M18D P5Y6M P7Y P8Y P0Y P7Y6M P6Y2M12D P6Y P6Y P5Y10M24D P5Y6M P5Y7M6D P0Y P6Y1M6D 0001393584 2021-01-01 2021-09-30 xbrli:shares 0001393584 us-gaap:CommonClassAMember 2021-10-31 0001393584 us-gaap:CommonClassBMember 2021-10-31 0001393584 us-gaap:CommonClassCMember 2021-10-31 iso4217:USD 0001393584 2021-09-30 0001393584 2020-12-31 iso4217:USD xbrli:shares 0001393584 us-gaap:CommonClassAMember 2021-09-30 0001393584 us-gaap:CommonClassAMember 2020-12-31 0001393584 us-gaap:CommonClassBMember 2021-09-30 0001393584 us-gaap:CommonClassBMember 2020-12-31 0001393584 us-gaap:CommonClassCMember 2021-09-30 0001393584 us-gaap:CommonClassCMember 2020-12-31 0001393584 2021-07-01 2021-09-30 0001393584 2020-07-01 2020-09-30 0001393584 2020-01-01 2020-09-30 0001393584 us-gaap:CommonStockMember 2020-12-31 0001393584 us-gaap:TreasuryStockMember 2020-12-31 0001393584 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001393584 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001393584 us-gaap:RetainedEarningsAppropriatedMember 2020-12-31 0001393584 us-gaap:ParentMember 2020-12-31 0001393584 us-gaap:NoncontrollingInterestMember 2020-12-31 0001393584 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001393584 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001393584 us-gaap:ParentMember 2021-01-01 2021-03-31 0001393584 2021-01-01 2021-03-31 0001393584 us-gaap:TreasuryStockMember 2021-01-01 2021-03-31 0001393584 us-gaap:RetainedEarningsAppropriatedMember 2021-01-01 2021-03-31 0001393584 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-03-31 0001393584 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-03-31 0001393584 us-gaap:CommonStockMember 2021-03-31 0001393584 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001393584 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0001393584 us-gaap:RetainedEarningsAppropriatedMember 2021-03-31 0001393584 us-gaap:ParentMember 2021-03-31 0001393584 us-gaap:NoncontrollingInterestMember 2021-03-31 0001393584 2021-03-31 0001393584 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001393584 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001393584 us-gaap:ParentMember 2021-04-01 2021-06-30 0001393584 2021-04-01 2021-06-30 0001393584 us-gaap:RetainedEarningsAppropriatedMember 2021-04-01 2021-06-30 0001393584 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-04-01 2021-06-30 0001393584 us-gaap:NoncontrollingInterestMember 2021-04-01 2021-06-30 0001393584 us-gaap:CommonStockMember 2021-06-30 0001393584 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001393584 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0001393584 us-gaap:RetainedEarningsAppropriatedMember 2021-06-30 0001393584 us-gaap:ParentMember 2021-06-30 0001393584 us-gaap:NoncontrollingInterestMember 2021-06-30 0001393584 2021-06-30 0001393584 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001393584 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001393584 us-gaap:ParentMember 2021-07-01 2021-09-30 0001393584 us-gaap:RetainedEarningsAppropriatedMember 2021-07-01 2021-09-30 0001393584 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-01 2021-09-30 0001393584 us-gaap:NoncontrollingInterestMember 2021-07-01 2021-09-30 0001393584 us-gaap:CommonStockMember 2021-09-30 0001393584 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001393584 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-30 0001393584 us-gaap:RetainedEarningsAppropriatedMember 2021-09-30 0001393584 us-gaap:ParentMember 2021-09-30 0001393584 us-gaap:NoncontrollingInterestMember 2021-09-30 0001393584 us-gaap:ConvertiblePreferredStockMember 2019-12-31 0001393584 us-gaap:CommonStockMember 2019-12-31 0001393584 us-gaap:TreasuryStockMember 2019-12-31 0001393584 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001393584 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001393584 us-gaap:RetainedEarningsAppropriatedMember 2019-12-31 0001393584 us-gaap:ParentMember 2019-12-31 0001393584 us-gaap:NoncontrollingInterestMember 2019-12-31 0001393584 2019-12-31 0001393584 us-gaap:ConvertiblePreferredStockMember 2020-01-01 2020-03-31 0001393584 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0001393584 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0001393584 us-gaap:ParentMember 2020-01-01 2020-03-31 0001393584 2020-01-01 2020-03-31 0001393584 us-gaap:TreasuryStockMember 2020-01-01 2020-03-31 0001393584 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0001393584 us-gaap:RetainedEarningsAppropriatedMember 2020-01-01 2020-03-31 0001393584 us-gaap:NoncontrollingInterestMember 2020-01-01 2020-03-31 0001393584 us-gaap:ConvertiblePreferredStockMember 2020-03-31 0001393584 us-gaap:CommonStockMember 2020-03-31 0001393584 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001393584 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0001393584 us-gaap:RetainedEarningsAppropriatedMember 2020-03-31 0001393584 us-gaap:ParentMember 2020-03-31 0001393584 us-gaap:NoncontrollingInterestMember 2020-03-31 0001393584 2020-03-31 0001393584 us-gaap:ConvertiblePreferredStockMember 2020-04-01 2020-06-30 0001393584 us-gaap:CommonStockMember 2020-04-01 2020-06-30 0001393584 us-gaap:TreasuryStockMember 2020-04-01 2020-06-30 0001393584 us-gaap:ParentMember 2020-04-01 2020-06-30 0001393584 2020-04-01 2020-06-30 0001393584 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2020-06-30 0001393584 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-04-01 2020-06-30 0001393584 us-gaap:RetainedEarningsAppropriatedMember 2020-04-01 2020-06-30 0001393584 us-gaap:NoncontrollingInterestMember 2020-04-01 2020-06-30 0001393584 us-gaap:ConvertiblePreferredStockMember 2020-06-30 0001393584 us-gaap:CommonStockMember 2020-06-30 0001393584 us-gaap:TreasuryStockMember 2020-06-30 0001393584 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001393584 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0001393584 us-gaap:RetainedEarningsAppropriatedMember 2020-06-30 0001393584 us-gaap:ParentMember 2020-06-30 0001393584 us-gaap:NoncontrollingInterestMember 2020-06-30 0001393584 2020-06-30 0001393584 us-gaap:CommonStockMember 2020-07-01 2020-09-30 0001393584 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2020-09-30 0001393584 us-gaap:ParentMember 2020-07-01 2020-09-30 0001393584 us-gaap:TreasuryStockMember 2020-07-01 2020-09-30 0001393584 us-gaap:ConvertiblePreferredStockMember 2020-07-01 2020-09-30 0001393584 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0001393584 us-gaap:RetainedEarningsAppropriatedMember 2020-07-01 2020-09-30 0001393584 us-gaap:NoncontrollingInterestMember 2020-07-01 2020-09-30 0001393584 us-gaap:CommonStockMember 2020-09-30 0001393584 us-gaap:TreasuryStockMember 2020-09-30 0001393584 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001393584 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-09-30 0001393584 us-gaap:RetainedEarningsAppropriatedMember 2020-09-30 0001393584 us-gaap:ParentMember 2020-09-30 0001393584 us-gaap:NoncontrollingInterestMember 2020-09-30 0001393584 2020-09-30 0001393584 us-gaap:SeriesCPreferredStockMember 2020-01-01 2020-03-31 0001393584 us-gaap:SeriesCPreferredStockMember 2020-04-01 2020-06-30 0001393584 us-gaap:CommonClassAMember 2020-07-01 2020-09-30 0001393584 us-gaap:CommonClassAMember us-gaap:PrivatePlacementMember 2020-07-01 2020-09-30 0001393584 amwl:ConversaHealthIncMember 2021-08-09 2021-08-09 0001393584 amwl:SilverCloudHealthHoldingsIncMember 2021-08-27 2021-08-27 0001393584 us-gaap:IPOMember 2020-09-21 2020-09-21 0001393584 2020-09-21 2020-09-21 xbrli:pure 0001393584 srt:MaximumMember 2021-01-01 2021-09-30 amwl:Segment 0001393584 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2021-09-30 0001393584 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2020-12-31 0001393584 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2021-07-01 2021-09-30 0001393584 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2020-07-01 2020-09-30 0001393584 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2021-01-01 2021-09-30 0001393584 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2020-01-01 2020-09-30 0001393584 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember amwl:CcacvJvLlcMember 2020-01-01 2020-12-31 0001393584 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember amwl:CcacvJvLlcMember 2020-12-31 0001393584 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember amwl:CcacvJvLlcMember 2021-01-01 2021-09-30 0001393584 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember amwl:CcacvJvLlcMember 2021-07-01 2021-09-30 0001393584 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember amwl:CcacvJvLlcMember 2020-07-01 2020-09-30 0001393584 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember amwl:CcacvJvLlcMember 2020-01-01 2020-09-30 0001393584 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember amwl:CcacvJvLlcMember 2021-09-30 0001393584 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember amwl:RelatedPartyCustomerOneMember 2021-01-01 2021-09-30 0001393584 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember amwl:RelatedPartyCustomerOneMember 2020-01-01 2020-12-31 0001393584 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember amwl:RelatedPartyCustomerOneMember 2021-07-01 2021-09-30 0001393584 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember amwl:RelatedPartyCustomerOneMember 2020-07-01 2020-09-30 0001393584 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember amwl:RelatedPartyCustomerOneMember 2021-01-01 2021-09-30 0001393584 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember amwl:RelatedPartyCustomerOneMember 2020-01-01 2020-09-30 0001393584 us-gaap:AccountingStandardsUpdate201813Member 2021-09-30 0001393584 us-gaap:AccountingStandardsUpdate201815Member 2021-09-30 0001393584 us-gaap:AccountingStandardsUpdate201912Member 2021-09-30 0001393584 amwl:AccountingStandardsUpdate202108Member 2021-09-30 0001393584 amwl:PlatformSubscriptionMember 2021-07-01 2021-09-30 0001393584 amwl:PlatformSubscriptionMember 2020-07-01 2020-09-30 0001393584 amwl:PlatformSubscriptionMember 2021-01-01 2021-09-30 0001393584 amwl:PlatformSubscriptionMember 2020-01-01 2020-09-30 0001393584 amwl:VisitsMember 2021-07-01 2021-09-30 0001393584 amwl:VisitsMember 2020-07-01 2020-09-30 0001393584 amwl:VisitsMember 2021-01-01 2021-09-30 0001393584 amwl:VisitsMember 2020-01-01 2020-09-30 0001393584 amwl:OthersMember 2021-07-01 2021-09-30 0001393584 amwl:OthersMember 2020-07-01 2020-09-30 0001393584 amwl:OthersMember 2021-01-01 2021-09-30 0001393584 amwl:OthersMember 2020-01-01 2020-09-30 0001393584 2020-01-01 2020-12-31 0001393584 us-gaap:UnbilledRevenuesMember 2021-09-30 0001393584 us-gaap:UnbilledRevenuesMember 2020-12-31 0001393584 2021-10-01 2021-09-30 0001393584 2021-01-01 2020-12-31 0001393584 srt:MinimumMember amwl:NtnMemberMember 2016-01-01 0001393584 srt:MaximumMember amwl:NtnMemberMember 2016-01-01 0001393584 amwl:NtnMemberMember 2021-07-01 2021-09-30 0001393584 amwl:NtnMemberMember 2020-07-01 2020-09-30 0001393584 amwl:NtnMemberMember 2021-01-01 2021-09-30 0001393584 amwl:NtnMemberMember 2020-01-01 2020-09-30 0001393584 us-gaap:NoncontrollingInterestMember amwl:NtnMemberMember 2021-09-30 0001393584 us-gaap:NoncontrollingInterestMember amwl:NtnMemberMember 2020-12-31 0001393584 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-09-30 0001393584 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2021-09-30 0001393584 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-09-30 0001393584 us-gaap:FairValueMeasurementsRecurringMember 2021-09-30 0001393584 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember amwl:ContingentConsiderationMember 2021-09-30 0001393584 us-gaap:FairValueMeasurementsRecurringMember amwl:ContingentConsiderationMember 2021-09-30 0001393584 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-09-30 0001393584 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MoneyMarketFundsMember 2020-12-31 0001393584 us-gaap:FairValueMeasurementsRecurringMember us-gaap:MoneyMarketFundsMember 2020-12-31 0001393584 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InvestmentsMember 2020-12-31 0001393584 us-gaap:FairValueMeasurementsRecurringMember us-gaap:InvestmentsMember 2020-12-31 0001393584 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001393584 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001393584 us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001393584 amwl:SilverCloudHealthHoldingsIncMember 2021-01-01 2021-09-30 0001393584 amwl:ConversaHealthIncMember 2021-01-01 2021-09-30 0001393584 us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2020-12-31 0001393584 amwl:SilverCloudHealthHoldingsIncMember us-gaap:CommonClassAMember 2021-08-27 2021-08-27 0001393584 amwl:SilverCloudHealthHoldingsIncMember 2021-08-27 0001393584 amwl:ConversaHealthIncMember us-gaap:CommonClassAMember 2021-08-09 2021-08-09 0001393584 amwl:ConversaHealthIncMember 2021-08-09 0001393584 amwl:SilverCloudHealthHoldingsIncMember us-gaap:TechnologyBasedIntangibleAssetsMember 2021-08-27 2021-08-27 0001393584 amwl:SilverCloudHealthHoldingsIncMember us-gaap:TradeNamesMember 2021-08-27 2021-08-27 0001393584 amwl:SilverCloudHealthHoldingsIncMember us-gaap:CustomerRelationshipsMember 2021-08-27 2021-08-27 0001393584 amwl:ConversaHealthIncMember us-gaap:TechnologyBasedIntangibleAssetsMember 2021-08-09 2021-08-09 0001393584 amwl:ConversaHealthIncMember us-gaap:TradeNamesMember 2021-08-09 2021-08-09 0001393584 amwl:ConversaHealthIncMember us-gaap:CustomerRelationshipsMember 2021-08-09 2021-08-09 0001393584 us-gaap:CustomerRelationshipsMember 2021-09-30 0001393584 us-gaap:ContractBasedIntangibleAssetsMember 2021-09-30 0001393584 us-gaap:TradeNamesMember 2021-09-30 0001393584 us-gaap:TechnologyBasedIntangibleAssetsMember 2021-09-30 0001393584 us-gaap:CustomerRelationshipsMember 2020-12-31 0001393584 us-gaap:ContractBasedIntangibleAssetsMember 2020-12-31 0001393584 us-gaap:TradeNamesMember 2020-12-31 0001393584 us-gaap:TechnologyBasedIntangibleAssetsMember 2020-12-31 0001393584 us-gaap:CustomerRelationshipsMember 2021-01-01 2021-09-30 0001393584 us-gaap:ContractBasedIntangibleAssetsMember 2021-01-01 2021-09-30 0001393584 us-gaap:TradeNamesMember 2021-01-01 2021-09-30 0001393584 us-gaap:TechnologyBasedIntangibleAssetsMember 2021-01-01 2021-09-30 0001393584 us-gaap:CustomerRelationshipsMember 2020-01-01 2020-12-31 0001393584 us-gaap:ContractBasedIntangibleAssetsMember 2020-01-01 2020-12-31 0001393584 us-gaap:TradeNamesMember 2020-01-01 2020-12-31 0001393584 us-gaap:TechnologyBasedIntangibleAssetsMember 2020-01-01 2020-12-31 0001393584 amwl:TwoThousandAndElevenLineOfCreditFacilityMember 2011-01-31 0001393584 us-gaap:LondonInterbankOfferedRateLIBORMember amwl:TwoThousandAndElevenLineOfCreditFacilityMember 2011-01-30 2011-01-31 0001393584 amwl:TwoThousandAndSeventeenAmendedLineOfCreditFacilityMember 2017-11-30 0001393584 amwl:TwoThousandAndSeventeenAmendedLineOfCreditFacilityMember 2021-09-30 0001393584 amwl:TwoThousandAndSeventeenAmendedLineOfCreditFacilityMember 2020-12-31 0001393584 amwl:RedeemableConvertiblePreferredStockSeriesAMember 2019-12-31 0001393584 amwl:RedeemableConvertiblePreferredStockSeriesBMember 2019-12-31 0001393584 amwl:RedeemableConvertiblePreferredStockSeriesCMember 2019-12-31 0001393584 us-gaap:SeriesCPreferredStockMember 2020-02-01 2020-02-29 0001393584 us-gaap:SeriesCPreferredStockMember 2020-02-29 0001393584 us-gaap:SeriesCPreferredStockMember 2020-05-01 2020-05-31 0001393584 us-gaap:SeriesCPreferredStockMember 2020-05-31 0001393584 us-gaap:ConvertiblePreferredStockMember 2020-09-30 0001393584 us-gaap:ConvertiblePreferredStockMember 2021-01-01 2021-09-30 0001393584 us-gaap:ConvertiblePreferredStockMember 2020-09-01 2020-09-30 0001393584 us-gaap:PreferredStockMember 2020-09-30 0001393584 us-gaap:CommonClassAMember 2020-09-01 2020-09-30 0001393584 us-gaap:CommonClassAMember 2020-09-30 0001393584 us-gaap:CommonClassCMember 2020-09-01 2020-09-30 0001393584 us-gaap:IPOMember 2020-09-01 2020-09-30 0001393584 us-gaap:IPOMember amwl:CommonStockClassAAndClassBMember 2020-09-01 2020-09-30 0001393584 us-gaap:CommonClassBMember 2020-09-30 0001393584 us-gaap:CommonClassCMember 2020-09-30 0001393584 us-gaap:CommonClassAMember 2021-01-01 2021-09-30 0001393584 us-gaap:CommonClassBMember 2021-01-01 2021-09-30 0001393584 us-gaap:CommonClassCMember 2021-01-01 2021-09-30 0001393584 amwl:TwoThousandAndTwentyEquityIncentivePlanMember 2020-12-31 0001393584 amwl:TwoThousandAndTwentyEquityIncentivePlanMember 2021-01-01 2021-09-30 0001393584 amwl:TwoThousandAndTwentyEquityIncentivePlanMember 2021-09-30 0001393584 amwl:TwoThousandAndTwentyEquityIncentivePlanMember 2020-01-01 2020-12-31 0001393584 amwl:TwoThousandAndTwentyEquityIncentivePlanMember 2020-01-01 2020-09-30 0001393584 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockMember amwl:ExecutiveEquityAwardsMember 2021-01-01 2021-09-30 0001393584 srt:ChiefExecutiveOfficerMember us-gaap:ShareBasedCompensationAwardTrancheOneMember us-gaap:RestrictedStockMember amwl:ExecutiveEquityAwardsMember 2021-01-01 2021-09-30 0001393584 srt:ChiefExecutiveOfficerMember us-gaap:ShareBasedCompensationAwardTrancheOneMember us-gaap:RestrictedStockMember amwl:ExecutiveEquityAwardsMember 2020-09-01 2020-09-30 0001393584 srt:ChiefExecutiveOfficerMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember us-gaap:RestrictedStockMember amwl:ExecutiveEquityAwardsMember 2021-01-01 2021-09-30 0001393584 srt:ChiefExecutiveOfficerMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember us-gaap:RestrictedStockMember amwl:ExecutiveEquityAwardsMember 2020-09-01 2020-09-30 0001393584 us-gaap:RestrictedStockMember srt:ChiefExecutiveOfficerMember amwl:ExecutiveEquityAwardsMember 2021-09-30 0001393584 amwl:ExecutiveEquityAwardsMember 2021-01-01 2021-09-30 0001393584 us-gaap:RestrictedStockMember 2020-01-01 2020-12-31 0001393584 us-gaap:RestrictedStockMember 2021-01-01 2021-09-30 0001393584 us-gaap:RestrictedStockMember srt:MinimumMember 2020-01-01 2020-12-31 0001393584 us-gaap:RestrictedStockMember srt:MaximumMember 2020-01-01 2020-12-31 0001393584 us-gaap:RestrictedStockMember srt:MinimumMember 2021-01-01 2021-09-30 0001393584 us-gaap:RestrictedStockMember srt:MaximumMember 2021-01-01 2021-09-30 0001393584 us-gaap:RestrictedStockUnitsRSUMember 2020-12-31 0001393584 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-09-30 0001393584 us-gaap:RestrictedStockUnitsRSUMember 2021-09-30 0001393584 us-gaap:RestrictedStockMember 2020-01-01 2020-09-30 0001393584 amwl:TwoThousandAndTwentyEmployeeStockPurchasePlanMember 2020-08-31 0001393584 amwl:TwoThousandAndTwentyEmployeeStockPurchasePlanMember 2021-01-01 2021-09-30 0001393584 amwl:TwoThousandAndTwentyEmployeeStockPurchasePlanMember 2021-07-01 2021-09-30 0001393584 amwl:TwoThousandAndTwentyEmployeeStockPurchasePlanMember 2021-09-30 0001393584 amwl:TwoThousandAndTwentyEmployeeStockPurchasePlanMember 2020-01-01 2020-09-30 0001393584 amwl:TwoThousandAndTwentyEmployeeStockPurchasePlanMember 2020-07-01 2020-09-30 0001393584 us-gaap:CostOfSalesMember 2021-07-01 2021-09-30 0001393584 us-gaap:CostOfSalesMember 2020-07-01 2020-09-30 0001393584 us-gaap:CostOfSalesMember 2021-01-01 2021-09-30 0001393584 us-gaap:CostOfSalesMember 2020-01-01 2020-09-30 0001393584 us-gaap:ResearchAndDevelopmentExpenseMember 2021-07-01 2021-09-30 0001393584 us-gaap:ResearchAndDevelopmentExpenseMember 2020-07-01 2020-09-30 0001393584 us-gaap:ResearchAndDevelopmentExpenseMember 2021-01-01 2021-09-30 0001393584 us-gaap:ResearchAndDevelopmentExpenseMember 2020-01-01 2020-09-30 0001393584 us-gaap:SellingAndMarketingExpenseMember 2021-07-01 2021-09-30 0001393584 us-gaap:SellingAndMarketingExpenseMember 2020-07-01 2020-09-30 0001393584 us-gaap:SellingAndMarketingExpenseMember 2021-01-01 2021-09-30 0001393584 us-gaap:SellingAndMarketingExpenseMember 2020-01-01 2020-09-30 0001393584 us-gaap:GeneralAndAdministrativeExpenseMember 2021-07-01 2021-09-30 0001393584 us-gaap:GeneralAndAdministrativeExpenseMember 2020-07-01 2020-09-30 0001393584 us-gaap:GeneralAndAdministrativeExpenseMember 2021-01-01 2021-09-30 0001393584 us-gaap:GeneralAndAdministrativeExpenseMember 2020-01-01 2020-09-30 0001393584 us-gaap:CommonStockMember amwl:EquityAwardPlanMember 2021-09-30 0001393584 us-gaap:CommonStockMember amwl:EquityAwardPlanMember 2021-01-01 2021-09-30 0001393584 us-gaap:IndemnificationGuaranteeMember 2021-01-01 2021-09-30 0001393584 us-gaap:IndemnificationGuaranteeMember 2020-01-01 2020-12-31 0001393584 us-gaap:PendingLitigationMember 2021-09-30 0001393584 us-gaap:PendingLitigationMember 2020-12-31 0001393584 amwl:NewLeaseMember 2021-09-30 0001393584 amwl:TevaPharmaceuticalsIndustriesLtdMember 2020-12-31 0001393584 amwl:TevaPharmaceuticalsIndustriesLtdMember 2020-07-01 2020-09-30 0001393584 amwl:TevaPharmaceuticalsIndustriesLtdMember 2020-01-01 2020-09-30 0001393584 amwl:PhilipsHoldingUsaIncMember 2020-12-31 0001393584 amwl:PhilipsHoldingUsaIncMember 2021-06-01 2021-06-30 0001393584 amwl:PhilipsHoldingUsaIncMember 2020-07-01 2020-09-30 0001393584 amwl:PhilipsHoldingUsaIncMember 2020-01-01 2020-09-30 0001393584 amwl:AnthemIncMember 2020-12-31 0001393584 amwl:AnthemIncMember 2020-07-01 2020-09-30 0001393584 amwl:AnthemIncMember 2020-01-01 2020-09-30 0001393584 amwl:ClevelandClinicMember 2021-09-30 0001393584 amwl:ClevelandClinicMember 2020-12-31 0001393584 amwl:ClevelandClinicMember 2021-07-01 2021-09-30 0001393584 amwl:ClevelandClinicMember 2020-07-01 2020-09-30 0001393584 amwl:ClevelandClinicMember 2021-01-01 2021-09-30 0001393584 amwl:ClevelandClinicMember 2020-01-01 2020-09-30 0001393584 amwl:CcawJvLlcMember 2020-01-01 2020-12-31 0001393584 amwl:CcawJvLlcMember 2021-01-01 2021-09-30 0001393584 amwl:CcawJvLlcMember 2020-12-31 0001393584 amwl:CcawJvLlcMember 2021-07-01 2021-09-30 0001393584 amwl:CcawJvLlcMember 2020-07-01 2020-09-30 0001393584 amwl:CcawJvLlcMember 2020-01-01 2020-09-30 0001393584 amwl:CcawJvLlcMember 2021-09-30 0001393584 amwl:UnvestedRestrictedStockMember 2021-07-01 2021-09-30 0001393584 amwl:UnvestedRestrictedStockMember 2020-07-01 2020-09-30 0001393584 amwl:UnvestedRestrictedStockMember 2021-01-01 2021-09-30 0001393584 amwl:UnvestedRestrictedStockMember 2020-01-01 2020-09-30 0001393584 us-gaap:EmployeeStockOptionMember 2021-07-01 2021-09-30 0001393584 us-gaap:EmployeeStockOptionMember 2020-07-01 2020-09-30 0001393584 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-09-30 0001393584 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-09-30

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2021

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from                      to                     

Commission File Number: 001-39515

 

American Well Corporation

(Exact name of registrant as specified in its charter)

 

 

Delaware

20-5009396

(State of incorporation)

(I.R.S. Employer
Identification Number)

 

75 State Street, 26th Floor

Boston, MA 02109

(Address of registrant’s principal executive offices)

(617) 204-3500

(Registrant’s telephone number, including area code)

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes   No  

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes      No  

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definition of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

 

Accelerated filer

 

 

 

 

 

Non-accelerated filer

 

Smaller reporting company

 

 

 

 

 

 

 

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes      No  

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading Symbol(s)

 

Name of each exchange on which registered

Class A common stock,
par value of $0.01 per share

 

AMWL

 

The New York Stock Exchange

 

As of October 31, 2021, the number of shares of the registrant’s Class A common stock outstanding was 227,489,928, the number of shares of the registrant’s Class B common stock outstanding was 26,913,579 and the number of shares of the registrant’s Class C common stock outstanding was 5,555,555.

 

 


 

American Well Corporation

QUARTERLY REPORT ON FORM 10-Q

For the period ended September 30, 2021

TABLE OF CONTENTS

 

 

 

Page

 

PART I

Financial Information

3

Item 1.

Financial Statements

3

 

Condensed Consolidated Balance Sheet as of September 30, 2021 (unaudited) and December 31, 2020

3

 

Condensed Consolidated Statement of Operations and Comprehensive Loss (unaudited) for the three and nine months ended September 30, 2021 and 2020

4

 

Condensed Consolidated Statement of Stockholders’ Equity (Deficit) (unaudited) for the three and nine months ended September 30, 2021 and 2020

5

 

Condensed Consolidated Statement of Cash Flows (unaudited) for the nine months ended September 30, 2021 and 2020

7

 

Notes to the Unaudited Condensed Consolidated Financial Statements

8

Item 2

Management’s Discussion and Analysis of Financial Condition and Results of Operations

26

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

38

Item 4.

Controls and Procedures

39

PART II

Other Information

42

Item 1.

Legal Proceedings

42

Item 1A.

Risk Factors

42

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

43

Item 3.

Defaults Upon Senior Securities

44

Item 4.

Mine Safety Disclosures

44

Item 5.

Other Information

44

Item 6.

Exhibits

45

 

 

 


 

 

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements

AMERICAN WELL CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share and per share amounts)

(unaudited)

 

 

September 30, 2021

 

 

December 31, 2020

 

Assets

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

790,402

 

 

$

941,616

 

Investments

 

 

 

 

 

99,963

 

Restricted cash

 

 

 

 

 

1,095

 

Accounts receivable ($497 and $12,053, from related parties and net of

   allowances of $1,497 and $1,556, respectively)

 

 

39,851

 

 

 

45,296

 

Inventories

 

 

9,100

 

 

 

9,128

 

Deferred contract acquisition costs

 

 

1,339

 

 

 

2,134

 

Prepaid expenses and other current assets

 

 

13,902

 

 

 

14,055

 

Total current assets

 

 

854,594

 

 

 

1,113,287

 

Restricted cash

 

 

795

 

 

 

 

Property and equipment, net

 

 

2,714

 

 

 

3,836

 

Goodwill

 

 

443,903

 

 

 

193,877

 

Intangible assets, net

 

 

159,926

 

 

 

55,528

 

Operating lease right-of-use asset

 

 

17,780

 

 

 

6,609

 

Deferred contract acquisition costs, net of current portion

 

 

1,921

 

 

 

1,327

 

Other assets

 

 

1,520

 

 

 

1,430

 

Investment in minority owned joint venture

 

 

1,205

 

 

 

752

 

Total assets

 

$

1,484,358

 

 

$

1,376,646

 

Liabilities, Convertible Preferred Stock and Stockholders’ Deficit

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Accounts payable

 

$

5,278

 

 

$

5,797

 

Accrued expenses and other current liabilities

 

 

45,910

 

 

 

42,135

 

Contingent consideration liabilities

 

 

11,850

 

 

 

 

Operating lease liability, current

 

 

3,121

 

 

 

6,357

 

Deferred revenue ($683 and $14,421 from related parties, respectively)

 

 

60,949

 

 

 

66,693

 

Total current liabilities

 

 

127,108

 

 

 

120,982

 

Other long-term liabilities

 

 

4,210

 

 

 

64

 

Contingent consideration liabilities, net of current portion

 

 

33,340

 

 

 

 

 

Operating lease liability, net of current portion

 

 

14,988

 

 

 

1,296

 

Deferred revenue, net of current portion ($26 and $486 from related

   parties, respectively)

 

 

7,050

 

 

 

8,107

 

Total liabilities

 

 

186,696

 

 

 

130,449

 

Commitments and contingencies (Note 12)

 

 

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

 

 

 

Preferred stock, $0.01 par value; 100,000,000 shares authorized, no shares

   issued or outstanding as of September 30, 2021 and as of December 31, 2020

 

 

 

 

 

 

Common stock, $0.01 par value; 1,000,000,000 Class A shares authorized, 227,158,943 and

   201,488,097 shares issued, and 227,158,943 and 200,751,168 shares outstanding, respectively;

   100,000,000 Class B shares authorized, 26,650,761 and 30,427,128 shares issued, and 26,650,761

   and 29,297,382 shares outstanding, respectively; 200,000,000 Class C shares authorized 5,555,555

   issued and outstanding as of September 30, 2021 and December 31, 2020

 

 

2,595

 

 

 

2,357

 

Treasury stock, no shares and 1,866,675 shares as of September 30, 2021

   and December 31, 2020, respectively

 

 

 

 

 

(37,568

)

Additional paid-in capital

 

 

2,038,012

 

 

 

1,841,405

 

Accumulated other comprehensive income

 

 

(2,237

)

 

 

297

 

Accumulated deficit

 

 

(762,441

)

 

 

(582,359

)

Total American Well Corporation stockholders’ equity

 

 

1,275,929

 

 

 

1,224,132

 

Non-controlling interest

 

 

21,733

 

 

 

22,065

 

Total stockholders’ equity

 

 

1,297,662

 

 

 

1,246,197

 

Total liabilities and stockholders’ equity

 

$

1,484,358

 

 

$

1,376,646

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

3


 

AMERICAN WELL CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(in thousands, except share and per share amounts)

(unaudited)

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Revenue

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

($698, $15,912, $11,005 and $29,160 from related parties, respectively)

 

$

62,223

 

 

$

62,551

 

 

$

180,039

 

 

$

184,833

 

Costs and operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Costs of revenue, excluding depreciation and amortization of intangible assets

 

 

35,184

 

 

 

42,116

 

 

 

104,778

 

 

 

118,969

 

Research and development

 

 

27,399

 

 

 

25,275

 

 

 

72,817

 

 

 

57,848

 

Sales and marketing

 

 

16,370

 

 

 

13,758

 

 

 

44,891

 

 

 

39,978

 

General and administrative

 

 

34,380

 

 

 

43,113

 

 

 

79,946

 

 

 

138,537

 

Depreciation and amortization expense

 

 

4,340

 

 

 

2,576

 

 

 

9,330

 

 

 

7,371

 

Total costs and operating expenses

 

 

117,673

 

 

 

126,838

 

 

 

311,762

 

 

 

362,703

 

Loss from operations

 

 

(55,450

)

 

 

(64,287

)

 

 

(131,723

)

 

 

(177,870

)

Interest income and other (expense) income, net

 

 

(382

)

 

 

255

 

 

 

(97

)

 

 

1,410

 

Loss before expense from income taxes and loss from

   equity method investment

 

 

(55,832

)

 

 

(64,032

)

 

 

(131,820

)

 

 

(176,460

)

Benefit (Expense) from income taxes

 

 

5,454

 

 

 

(78

)

 

 

5,042

 

 

 

(330

)

Loss from equity method investment

 

 

(554

)

 

 

(486

)

 

 

(2,095

)

 

 

(1,250

)

Net loss

 

 

(50,932

)

 

 

(64,596

)

 

 

(128,873

)

 

 

(178,040

)

Net income (loss) attributable to non-controlling interest

 

 

562

 

 

 

(1,515

)

 

 

(332

)

 

 

(3,920

)

Net loss attributable to American Well Corporation

 

$

(51,494

)

 

$

(63,081

)

 

$

(128,541

)

 

$

(174,120

)

Net loss per share attributable to common stockholders,

   basic and diluted

 

$

(0.20

)

 

$

(0.92

)

 

$

(0.51

)

 

$

(3.38

)

Weighted-average common shares outstanding, basic and diluted

 

 

257,283,961

 

 

 

68,499,106

 

 

 

250,115,414

 

 

 

51,492,988

 

Net loss

 

$

(50,932

)

 

$

(64,596

)

 

$

(128,873

)

 

$

(178,040

)

Other comprehensive income (loss), net of tax:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unrealized gain on available-for-sale investments

 

 

0

 

 

 

(135

)

 

 

(85

)

 

 

(415

)

Foreign currency translation

 

 

(2,377

)

 

 

37

 

 

 

(2,449

)

 

 

215

 

Comprehensive loss

 

 

(53,309

)

 

 

(64,694

)

 

 

(131,407

)

 

 

(178,240

)

Less: Comprehensive loss attributable to

   non-controlling interest

 

 

562

 

 

 

(1,515

)

 

 

(332

)

 

 

(3,920

)

Comprehensive loss attributable to American Well Corporation

 

$

(53,871

)

 

$

(63,179

)

 

$

(131,075

)

 

$

(174,320

)

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

4


 

 

AMERICAN WELL CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT)

(in thousands, except share amounts)

(unaudited)

 

 

 

Common Stock

 

 

Treasury

 

 

Additional

Paid-In

 

 

Accumulated

Other

Comprehensive

 

 

Accumulated

 

 

American Well

Corporation

Stockholders’

 

 

Noncontrolling

 

 

Total

Stockholders’

 

 

 

Shares

 

 

Amount

 

 

Stock

 

 

Capital

 

 

Income (Loss)

 

 

Deficit

 

 

Equity

 

 

Interest

 

 

Equity

 

Balances as of January 1, 2021

 

 

235,604,105

 

 

$

2,357

 

 

$

(37,568

)

 

$

1,841,405

 

 

$

297

 

 

$

(582,359

)

 

$

1,224,132

 

 

$

22,065

 

 

$

1,246,197

 

Exercise of common stock options

 

 

3,474,375

 

 

 

34

 

 

 

 

 

 

10,096

 

 

 

 

 

 

 

 

 

10,130

 

 

 

 

 

 

10,130

 

Vesting of restricted stock units

 

 

853,842

 

 

 

9

 

 

 

 

 

 

(9

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Retirement of treasury stock purchased in 2020

 

 

 

 

 

 

 

 

37,568

 

 

 

(15

)

 

 

 

 

 

(37,553

)

 

 

 

 

 

 

 

 

 

Shares withheld related to net share settlement and retired treasury stock in 2021

 

 

(402,060

)

 

 

(4

)

 

 

 

 

 

4

 

 

 

 

 

 

(9,771

)

 

 

(9,771

)

 

 

 

 

 

(9,771

)

Stock-based compensation expense

 

 

 

 

 

 

 

 

 

 

 

8,642

 

 

 

 

 

 

 

 

 

8,642

 

 

 

 

 

 

8,642

 

Currency translation adjustment

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(52

)

 

 

 

 

 

(52

)

 

 

 

 

 

(52

)

Unrealized gains on available-for-sale

   securities, net of tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

34

 

 

 

 

 

 

34

 

 

 

 

 

 

34

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(39,188

)

 

 

(39,188

)

 

 

(617

)

 

 

(39,805

)

Balances as of March 31, 2021

 

 

239,530,262

 

 

 

2,396

 

 

 

 

 

 

1,860,123

 

 

 

279

 

 

 

(668,871

)

 

 

1,193,927

 

 

 

21,448

 

 

 

1,215,375

 

Exercise of common stock options

 

 

1,812,491

 

 

 

18

 

 

 

 

 

 

6,656

 

 

 

 

 

 

 

 

 

6,674

 

 

 

 

 

 

6,674

 

Vesting of restricted stock units

 

 

844,900

 

 

 

9

 

 

 

 

 

 

(9

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares withheld related to net share settlement and retired treasury stock in 2021

 

 

(68,750

)

 

 

(1

)

 

 

 

 

 

1

 

 

 

 

 

 

(1,857

)

 

 

(1,857

)

 

 

 

 

 

(1,857

)

Stock-based compensation expense

 

 

 

 

 

 

 

 

 

 

 

10,726

 

 

 

 

 

 

 

 

 

10,726

 

 

 

 

 

 

10,726

 

Currency translation adjustment

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(20

)

 

 

 

 

 

(20

)

 

 

 

 

 

(20

)

Unrealized gains on available-for-sale

   securities, net of tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(119

)

 

 

 

 

 

(119

)

 

 

 

 

 

(119

)

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(37,859

)

 

 

(37,859

)

 

 

(277

)

 

 

(38,136

)

Balances as of June 30, 2021

 

 

242,118,903

 

 

 

2,422

 

 

 

 

 

 

1,877,497

 

 

 

140

 

 

 

(708,587

)

 

 

1,171,472

 

 

 

21,171

 

 

 

1,192,643

 

Exercise of common stock options

 

 

491,598

 

 

 

5

 

 

 

 

 

 

1,872

 

 

 

 

 

 

 

 

 

1,877

 

 

 

 

 

 

1,877

 

Vesting of restricted stock units

 

 

3,989,239

 

 

 

40

 

 

 

 

 

 

(40

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares withheld related to net share settlement and retired treasury stock in 2021

 

 

(211,494

)

 

 

(2

)

 

 

 

 

 

2

 

 

 

 

 

 

(2,360

)

 

 

(2,360

)

 

 

 

 

 

(2,360

)

Issuance of stock under employee stock purchase plan

 

 

178,021

 

 

 

2

 

 

 

 

 

 

1,597

 

 

 

 

 

 

 

 

 

1,599

 

 

 

 

 

 

1,599

 

Issuance of common stock in acquisitions

 

 

12,798,992

 

 

 

128

 

 

 

 

 

 

143,979

 

 

 

 

 

 

 

 

 

144,107